Therefore, further studies are required to elucidate the precise role of PKM2 as a target for detecting DN and to determine the urinary level of PKM2 in patients with diabetes so as to facilitate early intervention in DN progression. This evidence concerns the gene PKM and liver dysplastic nodule.